Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with
darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer.
Epoetin alfa and darbepoetin alfa are genetically engineered proteins that stimulate red
blood cell production.